C. Nichols
Corporate Officer/Principal bei ALKERMES PLC
Vermögen: 2 Mio $ am 31.03.2024
Profil
C.
Todd Nichols is currently the Chief Commercial Officer & Senior Vice President at Alkermes Plc.
Prior to his current position, he served as the Senior Vice President-Sales & Marketing at Alkermes, Inc. from 2019 to 2020.
Before that, he was the Vice President-Marketing & Sales at Celgene Corp.
from 2018 to 2019.
He also held a position as Vice President-US Sales & Field Operation at Biogen, Inc. Mr. Nichols completed his undergraduate degree at Elon University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2024 | 65 911 ( 0,04% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von C. Nichols
| Unternehmen | Position | Beginn |
|---|---|---|
| ALKERMES PLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von C. Nichols
| Unternehmen | Position | Ende |
|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Sales & Marketing | 01.05.2020 |
| CELGENE | Sales & Marketing | 01.01.2019 |
| BIOGEN INC. | Sales & Marketing | 01.01.2017 |
Ausbildung von C. Nichols
| Elon University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
